1. Home
  2. Sexually Transmitted Infections
Global Antibiotic Research and Development Partnership

Sexually Transmitted Infections

Last updated: 24/11/2021
IATI Identifier: CH-FDJP-CHE331930936-STI-20
Project disclaimer
Disclaimer: The data for this page has been produced from IATI data published by Global Antibiotic Research and Development Partnership.


Gonorrhoea is caused by the bacteria Neisseria gonorrhoeae, which has progressively developed resistance to globally recommended treatments and has been identified by the World Health Organization as a priority infection urgently requiring new antibiotics. To address the lack of effective drugs, the Global Antibiotic Research and Development Partnership (GARDP) is developing a new treatment for gonorrhoea and is working to ensure it is available to everyone who needs it, wherever they live.


The country, countries or regions that benefit from this Programme.
Global project
Disclaimer: Country borders do not necessarily reflect the UK Government's official position.

Status Implementation

The current stage of the Programme, consistent with the International Aid Transparency Initiative's (IATI) classifications.

Programme Spend

Programme budget and spend to date, as per the amounts loaded in financial system(s), and for which procurement has been finalised.

Participating Organisation(s)

Help with participating organisations
These organisations have received funding disbursements from this IATI activity.
  • Global Antibiotic Research and Development Partnership


Sector groups as a percentage of total Programme budget according to the OECD Development Assistance Committee (DAC) classifications.


A comparison across financial years of forecast budget and spend to date on the Programme.

Download IATI Data for CH-FDJP-CHE331930936-STI-20

Programme data last updated on 24/11/2021